Insider Stock Trading History of Singleton J Matthew


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Singleton J Matthew since year 2005. The trader's CIK number is 1243514. At the time of this reporting, Singleton J Matthew is the Director of Cubist Pharmaceuticals Inc . (stock ticker symbol CBST). See this page for all insider trading activities at Cubist Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Singleton J Matthew since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-06-06 CBST Cubist Pharmaceuticals Inc Option Ex 1,347 .00 0
2013-05-22 CBST Cubist Pharmaceuticals Inc Option Ex 27,500 16.14 443,712
2013-05-22 CBST Cubist Pharmaceuticals Inc Sale 27,500 55.48 1,525,755
2012-08-24 CBST Cubist Pharmaceuticals Inc Option Ex 2,500 10.09 25,225
2012-08-24 CBST Cubist Pharmaceuticals Inc Sale 2,500 45.52 113,800
2012-03-09 CBST Cubist Pharmaceuticals Inc Option Ex 10,000 .00 0
2012-03-09 CBST Cubist Pharmaceuticals Inc Sale 10,000 43.06 430,570
2012-02-03 CBST Cubist Pharmaceuticals Inc Option Ex 2,000 11.89 23,780
2012-02-03 CBST Cubist Pharmaceuticals Inc Sale 2,000 42.28 84,562
2009-01-14 CBST Cubist Pharmaceuticals Inc Option Ex 2,000 11.89 23,780
2009-01-14 CBST Cubist Pharmaceuticals Inc Sale 2,000 22.76 45,520
2008-12-17 CBST Cubist Pharmaceuticals Inc Option Ex 2,000 11.89 23,780
2008-12-17 CBST Cubist Pharmaceuticals Inc Sale 2,000 23.66 47,320
2008-11-19 CBST Cubist Pharmaceuticals Inc Option Ex 2,000 11.89 23,780
2008-11-19 CBST Cubist Pharmaceuticals Inc Sale 2,000 22.78 45,560
2008-10-29 CBST Cubist Pharmaceuticals Inc Option Ex 2,000 11.89 23,780
2008-10-29 CBST Cubist Pharmaceuticals Inc Sale 2,000 21.60 43,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Singleton J Matthew (Director of Cubist Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.